valine has been researched along with Schizophrenia in 142 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.41) | 18.7374 |
1990's | 3 (2.11) | 18.2507 |
2000's | 87 (61.27) | 29.6817 |
2010's | 48 (33.80) | 24.3611 |
2020's | 2 (1.41) | 2.80 |
Authors | Studies |
---|---|
Kremens, DE; McEvoy, JP | 1 |
Citrome, L; Saklad, SR | 1 |
Burke, J; Factor, SA; Hauser, RA; Jimenez, R; Knesevich, MA; Liang, GS; Marder, SR; O'Brien, CF; Ramirez, PM | 1 |
Amidani, F; Bartoli, F; Carrà, G; Castellano, F; Chiorazzi, A; Clerici, M; Crocamo, C; Gamba, G; Lax, A; Nicolini, G; Papagno, C | 1 |
Buckley, P; Chao, MV; Getz, M; Goetz, R; Kranz, TM; Malaspina, D; Messinger, JW; Nardi, AE; Peixoto, C; Veras, AB | 1 |
Burke, J; Correll, CU; Josiassen, RC; Liang, GS; O'Brien, CF | 1 |
Burke, J; Josiassen, RC; Kane, JM; Liang, GS; O'Brien, CF | 1 |
Burke, J; Correll, CU; Kane, JM; Liang, GS; O'Brien, CF | 1 |
Cai, S; Huang, K; Huang, L; Kang, Y; Liu, J; Lv, Y; Tian, J; Wang, H; Wang, J; Wang, Q; Wang, Y; Zhang, W | 1 |
Correll, CU; Cutler, AJ; Kane, JM; Liang, GS; McEvoy, JP; O'Brien, CF | 1 |
Correll, CU; Cutler, AJ; Kane, JM; Liang, GS; O'Brien, CF; Sajatovic, M; Stacy, M | 1 |
Chen, ZY; Cui, KY; Feng, X; Liu, LF; Sun, MM; Wang, Y; Yang, LM | 1 |
Apud, J; Berman, KF; Eisenberg, DP; Ianni, AM; Kohn, PD; Kolachana, B; Wei, SM; Weinberger, DR | 2 |
Cubells, JF; George, TP; Sacco, KA; Tang, YL; Wing, VC | 1 |
Correll, CU; Kane, JM; Lencz, T; Malhotra, AK; Miura, I; Nitta, M; Yabe, H; Zhang, JP | 1 |
Chang, YH; Chen, PS; Chen, SH; Chen, SL; Chu, CH; Hong, JS; Lee, IH; Lee, SY; Lu, RB; Wang, TY; Yang, YK | 1 |
Aas, M; Agartz, I; Andreassen, OA; Athanasiu, L; Bjella, T; Cattaneo, A; Djurovic, S; Hansson, L; Haukvik, UK; Melle, I; Tesli, M | 1 |
Fonseka, TM; Goldstein, BI; Gonçalves, VF; Kennedy, JL; Kennedy, SH; Lieberman, JA; Meltzer, HY; Müller, DJ; Tiwari, AK | 1 |
Eickhoff, CR; Eickhoff, SB; Janouschek, H; Nickl-Jockschat, T | 1 |
Fujihara, K; Kakizaki, T; Kaneko, R; Mikuni, M; Miwa, H; Tamamaki, N; Tanahira, C; Yanagawa, Y | 1 |
Alfimova, MV; Gabaeva, MV; Golimbet, VE; Korovaitseva, GI; Lezheiko, TV; Oleichik, IV; Stolyarov, SA | 1 |
Angrisano, T; Bertolino, A; Blasi, G; Bollati, V; Caforio, G; Calabrese, F; Cavalleri, T; Chiariotti, L; De Blasi, A; Di Giorgio, A; Fazio, L; Gelao, B; Iacovelli, L; Keller, S; Maddalena, G; Mancini, M; Masellis, R; Popolizio, T; Porcelli, A; Punzi, G; Quarto, T; Rampino, A; Riva, MA; Romano, R; Sinibaldi, L; Tarantini, L; Taurisano, P; Ursini, G | 1 |
Abdisalaam, S; Adams-Huet, B; Asaithamby, A; Birchfield, T; Ghose, S; Gleason, K; Jha, M; Mukherjee, S; Shukla, AA; Tamminga, CA | 1 |
Gogos, JA; Hill, RA; Notaras, MJ; van den Buuse, M | 1 |
Cristobal-Huerta, A; Hernández-Tamames, JA; Lopez-Garcia, P; Molero, P; Ortuño Sanchez-Pedreño, F; Young Espinoza, L | 1 |
Fang, H; Liu, XY; Soares, JC; Xu, G; Zhang, XY; Zhao, J; Zhen, YF | 1 |
Citrome, L | 1 |
Ettinger, U; Haraldsson, HM; Ingason, A; Magnusdottir, BB; Petursson, H; Sigmundsson, T; Sigurdsson, E | 2 |
Goghari, VM; Sponheim, SR | 1 |
An, H; Cho, SN; Choi, JE; Han, C; Joe, SH; Jung, IK; Kang, SG; Kim, L; Kim, SH; Kim, YK; Lee, HJ; Lee, MS; Park, YM | 1 |
Kálmán, J | 1 |
Boronow, JJ; Dickerson, FB; Origoni, AE; Stallings, CR; Sullens, A; Yolken, RH | 1 |
Docherty, AR; Sponheim, SR | 1 |
Ikeda, M; Inada, T; Iwata, N; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Okochi, T; Ozaki, N; Tomita, M; Yamanouchi, Y | 1 |
Burdick, KE; DeRosse, P; Kane, JM; Lencz, T; Lipsky, RH; Malhotra, AK | 1 |
Alvira-Botero, X; Aragüés, M; España-Serrano, L; Garrido, E; Hoenicka, J; Jiménez-Arriero, MA; Martínez, I; Palomo, T; Ponce, G; Rodríguez-Jiménez, R; Rubio, G; Santos, JL | 1 |
Aleksic, B; Ikeda, M; Inada, T; Iwata, N; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Kunugi, H; Okada, T; Okochi, T; Ozaki, N; Tomita, M; Yamanouchi, Y | 1 |
Fukuda, M; Kasai, K; Kawakubo, Y; Marumo, K; Sasaki, T; Takizawa, R; Tochigi, M | 1 |
Kim, JI; Kim, YH; Kong, BG; Lee, CH; Lee, JG; Lee, SJ; Park, SW | 1 |
Agartz, I; Andreassen, OA; Andreou, D; Djurovic, S; Hall, H; Hansen, T; Jönsson, EG; Lundmark, P; Melle, I; Saetre, P; Terenius, L; Timm, S; Werge, T | 1 |
Dorado, P; Guarino, E; Llerena, A; Sánchez-Romero, MA | 1 |
Bramon, E; Collier, DA; Fu, CH; McGuire, P; Mechelli, A; Murray, RM; Picchioni, M; Prata, DP; Toulopoulou, T; Walshe, M | 1 |
Bakker, SC; Hoogendoorn, ML; Hulshoff Pol, HE; Kahn, RS; Koolschijn, PC; van Haren, NE | 1 |
Bach Cuadra, M; Debbané, M; Eliez, S; Glaser, B; Ottet, MC; Schaer, M; Thiran, JP | 1 |
Apud, J; Berman, KF; Eisenberg, DP; Kohn, PD; Kolachana, B; Meyer-Lindenberg, A; Sarpal, D; Weinberger, DR; Wint, D | 1 |
Kang, CY; Liu, H; Shi, ZY; Xu, HH; Xu, XF; Yang, JZ | 1 |
Chen, DC; Fang, H; Hail, CN; Kosten, TR; Liu, H; Ma, QM; Wang, JD; Wang, Y; Wu, HR; Xiu, MH; Zhang, BS; Zhang, XY | 1 |
Angelucci, F; Bernardini, S; Bonaviri, G; Bossù, P; Bria, P; Caltagirone, C; Corvin, AP; Donohoe, G; Gill, M; Martinotti, G; Morris, DW; Rubino, IA; Siracusano, A; Spalletta, G; Spoletini, I | 1 |
Kang, C; Liu, H; Xu, X; Yang, J | 1 |
Agra, S; Arrojo, M; Brenlla, J; Costas, J; Ivorra, JL; Páramo, M; Paz, E; Ramos-Ríos, R; Sanjuán, J | 1 |
Duman, Z; Oztürk, M; Saruhan-Direskeneli, G; Uçok, A | 1 |
Agartz, I; Andreassen, OA; Athanasiu, L; Djurovic, S; Mattingsdal, M; Melle, I; Sundet, K; Wirgenes, KV | 1 |
Baig, BJ; Cunningham-Owens, DG; Hall, J; Job, DE; Johnstone, EC; Lawrie, SM; McIntosh, AM; Whalley, HC | 1 |
de Luca, V; Javaid, N; Kennedy, JL; Panariello, F; Souza, RP; Strauss, J; Tallerico, T; Wong, AH; Zai, CC | 1 |
Kazawa, T; Kuroki, N; Kuwabara, M; Maruki, T; Odagaki, Y; Toyoshima, R; Yamashita, H; Yoda, H | 1 |
Bernabeu, C; Campanera, S; Estrada, G; Fañanás, L; Fatjó-Vilas, M; Illa, JM; Martín, M; Miñano, MJ; Miralles, ML; Miret, S; Muñoz, MJ; Navarro, ME; Pulido, G; Toledo, E | 1 |
Agra, S; Arrojo, M; Brenlla, J; Costas, J; Páramo, M; Paz, E; Ramos-Ríos, R; Sanjuán, J; Tolosa, A | 1 |
Backens, M; Ekawardhani, S; Falkai, P; Gruber, O; Hasan, A; Meyer, J; Reith, W; Scherk, H; Schmitt, A; Schneider-Axmann, T; Wobrock, T | 1 |
Eack, SM; Iyengar, S; Keshavan, MS; Nimgaonkar, VL; Prasad, KM; Yolken, RH | 1 |
Fawzi, MM; Fawzy, N; Hashim, HM; Karam, RA | 1 |
Chen, DC; Haile, CN; Kosten, TA; Kosten, TR; Wu, HR; Xiu, MH; Zhang, WF; Zhang, XY; Zhou, DF | 1 |
Bhakta, SG; Malhotra, AK; Zhang, JP | 1 |
Arbez, N; Delisi, LE; Margolis, RL; Nucifora, FC; Nucifora, LG; Ross, CA; Sell, GL; Yu, L | 1 |
Bilder, RM; Chakos, M; Citrome, L; Cooper, TB; Czobor, P; Goldman, RS; Hoptman, MJ; Kennedy, JL; Kunz, M; Lieberman, JA; Lindenmayer, JP; Malhotra, AK; McEvoy, JP; Ni, X; Sheitman, B; Volavka, J | 1 |
Hou, G; Sha, W; Yao, H; Zhang, X; Zhang, Z | 1 |
Buchanan, RW; Mitchell, BD; Stine, OC; Thaker, GK; Wonodi, I | 1 |
Bajbouj, M; Ferro, EF; Gallinat, J; Goldman, D; Sander, T; Schlattmann, P; Winterer, G; Xu, K | 1 |
Hong, CJ; Lin, CH; Tsai, SJ; Yu, YW | 1 |
Burnet, PW; Harrison, PJ; Sodhi, MS; Tunbridge, E | 1 |
Boronow, JJ; Dickerson, FB; Origoni, AE; Stallings, CR; Yolken, RH | 1 |
Citrome, L; Czobor, P; Kennedy, JL; Lieberman, JA; Lindenmayer, JP; McEvoy, J; Ni, X; Nolan, K; Sheitman, B; Volavka, J | 1 |
Hong, CJ; Lai, IC; Liao, DL; Liou, YJ; Tsai, SJ | 1 |
Altamura, M; Bellomo, A; Bertolino, A; Blasi, G; Caforio, G; Callicott, JH; De Candia, M; Latorre, V; Mattay, VS; Nappi, G; Nardini, M; Papa, S; Petruzzella, V; Scarabino, T; Weinberger, DR | 1 |
Apud, JA; Egan, MF; Goldberg, TE; Kolachana, BS; Mishara, A; Weickert, TW; Weinberger, DR | 1 |
Ergul, E; Kara, I; Kaya, G; Kilic, G; Kucukali, I; Sazci, A | 1 |
Avila, MT; Hong, LE; Stine, OC; Thaker, GK; Wonodi, I | 1 |
Bai, YM; Chen, JY; Lai, IC; Liao, DL; Lin, CC; Lin, CY; Liou, YJ; Wang, YC; Yu, SC | 1 |
Breen, G; Cheung, JK; Crombie, C; Neves-Pereira, M; Pasdar, A; Sinclair, M; St Clair, DM; Walker, N; Yates, P; Zhang, F | 1 |
Fan, JB; Feng, GY; Gu, NF; He, L; Li, XW; St Clair, D; Sun, WW; Wang, HY; Zhang, CS | 1 |
Bowes, L; Clark, TG; Flint, J; Munafò, MR | 1 |
Baker, K; Baldeweg, T; Scambler, P; Sivagnanasundaram, S; Skuse, D | 1 |
Irukayama-Tomobe, Y; Iwayama, Y; Meerabux, J; Nagata, R; Ohba, H; Ohta, K; Sakurai, T; Shimizu, H; Toyota, T; Yamada, K; Yoshikawa, T; Yoshitsugu, K | 1 |
Cassano, P; Del Zompo, M; Galderisi, S; Invernizzi, G; Kirkpatrick, B; Maj, M; Mucci, A; Piccardi, P; Pini, S; Rossi, A; Severino, G; Stratta, P; Vita, A | 1 |
Amir, I; Buniak, F; Finkel, B; Frisch, A; Hermesh, H; Knoll, G; Michaelovsky, E; Poyurovsky, M; Weizman, R | 1 |
Bourdel, MC; Goldberger, C; Gourion, D; Krebs, MO; Leroy, S; Olié, JP | 1 |
Glaser, B; Kirov, GK; MacGregor, S; Norton, N; O'Donovan, MC; Owen, MJ; Williams, HJ; Williams, NM; Zammit, S | 1 |
Bhatnagar, P; Brahmachari, SK; Chauhan, C; Gupta, S; Jain, S; Janardhan Reddy, YC; Kubendran, S; Kukreti, R; Tripathi, S | 1 |
Harrison, PJ; Tunbridge, EM; Weinberger, DR | 1 |
Han, DH; Kee, BS; Lee, YS; Lyoo, IK; Min, KJ; Na, C; Park, DB | 1 |
Borkowska, A; Czerski, PM; Hauser, J; Kapelski, P; Leszczynska-Rodziewicz, A; Rybakowski, JK; Skibinska, M; Szczepankiewicz, A | 1 |
Aono, M; Hongwei, S; Iga, J; Ishimoto, Y; Kameoka, N; Kaneda, Y; Kinouchi, S; Numata, S; Ohmori, T; Ohta, K; Shibuya-Tayoshi, S; Sumitani, S; Taniguchi, T; Tayoshi, S; Tomotake, M; Ueno, S; Yamauchi, K | 1 |
Pae, CU | 1 |
Finch, T; Flory, JD; Goldman, D; Harvey, PD; Minzenberg, MJ; Mitropoulou, V; New, AS; Siever, LJ; Xu, K | 1 |
Coppola, R; Egan, MF; Goldberg, TE; Kolachana, BS; Weinberger, DR; Winterer, G | 1 |
Almasy, L; Dassori, A; Escamilla, M; Leach, RJ; Lew, DF; Liu, W; Montero, P; Raventos, H; Villegas, R; Walss-Bass, C | 1 |
Bilbao, JR; Castaño, L; Echevarria, E; Galdos, P; Isusi, P; Krabbendam, L; Martin-Pagola, A; Papiol, S; Van Os, J | 1 |
Andreasen, NC; Ho, BC; Librant, A; Milev, P; O'Leary, DS; Wassink, TH | 1 |
Ehlis, AC; Fallgatter, AJ; Herrmann, MJ; Lesch, KP; Reif, A | 1 |
Eichhammer, P; Hajak, G; Langguth, B; Sand, PG | 1 |
Cortés, MJ; Gutiérrez-Zotes, A; Jariod, M; Labad, A; Martorell, L; Mulet, B; Pérez, M; Valero, J; Vilella, E | 1 |
Baig, BJ; Hall, J; Job, D; Johnstone, EC; Lawrie, SM; Lymer, GK; McIntosh, AM; Miller, P; Moorhead, TW; Owens, DG; Porteous, D; Whalley, HC | 1 |
Bevacqua, MG; Bonvicini, C; Foresti, G; Gennarelli, M; Scassellati, C; Squitti, R; Tura, GB; Ventriglia, M | 1 |
Bruder, GE; Gilliam, TC; Kandel, ER; Keilp, JG; Kellendonk, CB; Polan, HJ; Simpson, EH; Xu, H | 1 |
Jayathilake, K; Meltzer, HY; Woodward, ND | 1 |
Barnett, JH; Golding, J; Goldman, D; Heron, J; Jones, PB; Ring, SM; Xu, K | 1 |
Bassett, AS; Caluseriu, O; Chow, EW; Weksberg, R; Young, DA | 1 |
de Cid, R; Estivill, X; González, JR; Gratacòs, M; Mercader, JM; Urretavizcaya, M | 1 |
Fukunaka, Y; Hori, H; Hwang, R; Matsumoto, C; Nakamura, J; Naoe, Y; Ohmori, O; Sakata, S; Shimizu, K; Shinkai, T; Utsunomiya, K | 2 |
Botes, WC; Deleuze, JF; Hitzeroth, A; Koen, L; Niehaus, DJ; Warnich, L | 1 |
Anselmetti, S; Bechi, M; Bosia, M; Cavallaro, R; Cocchi, F; Marino, E; Poletti, S; Smeraldi, E | 1 |
O'Donovan, MC; Owen, MJ; Williams, HJ | 1 |
Glatt, SJ; Kanazawa, T; Kia-Keating, B; Tsuang, MT; Yoneda, H | 1 |
Antonarakis, SE; Gothelf, D; Hallmayer, JF; Hinard, C; Hoeft, F; Morris, MA; Reiss, AL; Stoecker, JV | 1 |
Carracedo, A; Costas, J; Franco, N; Labad, A; Martorell, L; Roig, B; Valero, J; Vilella, E; Virgos, C | 1 |
Cañive, JM; Edgar, JC; Escamilla, MA; Lewis, SF; Lu, BY; Martin, KE; Miller, GA; Smith, AK | 1 |
Carter, CS; Ferrell, RE; Flory, JD; MacDonald, AW; Manuck, SB | 1 |
Jun, TY; Kim, JJ; Kim, TS; Lee, C; Lee, CU; Lee, SJ; Pae, CU; Paik, IH; Patkar, AA | 1 |
Boronow, JJ; Dickerson, FB; Origoni, AE; Stallings, C; Sullens, A; Yolken, RH | 1 |
Bertolino, A; Blasi, G; Caforio, G; Dallapiccola, B; Douzgou, S; Nardini, M; Rampino, A; Sinibaldi, L; Weinberger, DR | 1 |
Diaz-Asper, CM; Egan, MF; Goldberg, TE; Kolachana, BS; Straub, RE; Weinberger, DR | 1 |
Abramova, LI; Alfimova, MV; Ebstein, R; Golimbet, VE; Gritsenko, IK; Khlopina, IV; Lezheiko, TV; Strel'tsova, MA | 1 |
Dracheva, S; Haroutunian, V; Marcus, SM; Patel, N; Siever, LJ; Woo, DA | 1 |
Cao, LY; Kosten, TA; Kosten, TR; Li, J; Lu, L; Tan, YL; Wang, ZR; Wu, GY; Zhang, XY; Zhou, DF | 1 |
Cao, LY; Haile, CN; Kosten, TA; Kosten, TR; Li, J; Lu, L; Tan, YL; Wu, GY; Zhang, XY; Zhou, DF | 1 |
Andreasen, NC; Dawson, JD; Ho, BC; Wassink, TH | 1 |
Arranz, MJ; Carrasco-Marín, E; Crespo-Facorro, B; Leyva-Cobián, F; Mata, I; Pelayo-Terán, JM; Pérez-Iglesias, R; Vázquez-Barquero, JL | 1 |
Deckersbach, T; Freudenreich, O; Goff, DC; Halsted, CH; Henderson, DC; Roffman, JL; Weiss, AP; Wong, DH | 1 |
Silberschmidt, AL; Sponheim, SR | 1 |
Kawamura, Y; Kawasaki, Y; Kobayashi, S; Kurachi, M; Ozaki, N; Sasaoka, T; Seto, H; Suzuki, M; Takahashi, N; Takahashi, T; Tsuneki, H; Tsunoda, M; Zhou, SY | 1 |
Bilbao, JR; Castaño, L; Echevarria, E; Galdos, P; Isusi, P; Krabbendam, L; Martin-Pagola, A; Mengelers, R; Myin-Germeys, I; Papiol, S; van Os, J; van Winkel, R | 1 |
Carrasco-Marin, E; Crespo-Facorro, B; Gonzalez-Blanch, C; Mata, I; Pelayo-Teran, JM; Perez-Iglesias, R; Rodríguez-Sanchez, JM; Vazquez-Barquero, JL | 1 |
Hagino, H; Kawamura, Y; Kawasaki, Y; Kobayashi, S; Kurachi, M; Maeno, N; Niu, L; Ozaki, N; Sasaoka, T; Seto, H; Suzuki, M; Takahashi, N; Takahashi, T; Tsuneki, H; Tsunoda, M; Zhou, SY | 1 |
Buka, S; Cannon, TD; Torrey, EF; Yolken, R | 1 |
Lu, B; Martinowich, K | 1 |
Collier, DA; Li, T; Liu, X; Murray, RM; Sham, PC; Tang, X; Vallada, H; Xie, T | 1 |
Hemmings, GP; Wei, J | 1 |
Javitt, DC; Jotkowitz, A; Sircar, R; Zukin, SR | 1 |
Diamond, S; Hansen, S; Perry, TL; Stedman, D | 1 |
11 review(s) available for valine and Schizophrenia
Article | Year |
---|---|
BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Databases, Bibliographic; Female; Genotype; Humans; Male; Methionine; Middle Aged; Movement Disorders; Polymorphism, Single Nucleotide; Schizophrenia; Severity of Illness Index; Valine | 2014 |
Emerging pharmacological therapies in schizophrenia: what's new, what's different, what's next?
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Humans; Injections, Intramuscular; Paliperidone Palmitate; Piperazines; Quinolones; Schizophrenia; Tetrabenazine; Thiophenes; Valine | 2016 |
Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.
Topics: Adult; Case-Control Studies; Catechol O-Methyltransferase; Confidence Intervals; Databases, Bibliographic; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Japan; Male; Methionine; Middle Aged; Odds Ratio; Schizophrenia; Valine | 2009 |
BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis.
Topics: Adult; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Gene Frequency; Genotype; Humans; Japan; Linkage Disequilibrium; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Valine; Young Adult | 2009 |
The COMT Met158 allele and violence in schizophrenia: a meta-analysis.
Topics: Catechol O-Methyltransferase; Genetic Predisposition to Disease; Humans; MEDLINE; Methionine; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology; Valine; Violence | 2012 |
Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.
Topics: Amino Acid Substitution; Asian People; Case-Control Studies; Catechol O-Methyltransferase; China; Female; Gene Frequency; Genetic Predisposition to Disease; Genetics, Population; Humans; Male; Methionine; Polymorphism, Single Nucleotide; Schizophrenia; Valine | 2005 |
Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies.
Topics: Amino Acid Substitution; Case-Control Studies; Catechol O-Methyltransferase; Databases, Factual; Humans; Methionine; Schizophrenia; Software; Valine; White People | 2005 |
Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Brain-Derived Neurotrophic Factor; Case-Control Studies; Feeding and Eating Disorders; Female; Genetic Predisposition to Disease; Humans; Male; Mental Disorders; Methionine; Middle Aged; Polymorphism, Genetic; Schizophrenia; Substance-Related Disorders; Valine | 2007 |
Is COMT a susceptibility gene for schizophrenia?
Topics: Alleles; Catechol O-Methyltransferase; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 22; Dopamine; Genetic Predisposition to Disease; Humans; Methionine; Polymorphism, Genetic; Prefrontal Cortex; Schizophrenia; Valine | 2007 |
Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.
Topics: Amino Acid Substitution; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Humans; Methionine; Polymorphism, Single Nucleotide; Racial Groups; Schizophrenia; Valine | 2007 |
Cell biology of BDNF and its relevance to schizophrenia.
Topics: Amino Acid Substitution; Brain-Derived Neurotrophic Factor; Humans; Learning; Long-Term Potentiation; Memory; Methionine; Neuronal Plasticity; Polymorphism, Single Nucleotide; RNA, Messenger; Schizophrenia; Synapses; Valine | 2008 |
17 trial(s) available for valine and Schizophrenia
Article | Year |
---|---|
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Topics: Abnormal Involuntary Movement Scale; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine | 2017 |
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Long Term Adverse Effects; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study.
Topics: Adrenergic Uptake Inhibitors; Affective Disorders, Psychotic; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Least-Squares Analysis; Outcome Assessment, Health Care; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine | 2018 |
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Topics: Aged; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Minimal Clinically Important Difference; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine; Vesicular Monoamine Transport Proteins | 2019 |
Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus.
Topics: Acyclovir; Adult; Antipsychotic Agents; Antiviral Agents; Baltimore; Comorbidity; Cytomegalovirus Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Valacyclovir; Valine | 2009 |
Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.
Topics: Acyclovir; Adolescent; Adult; Antipsychotic Agents; Antiviral Agents; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Learning; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Schizophrenia; Valacyclovir; Valine; Young Adult | 2013 |
Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; China; Female; Genotype; Ginkgo biloba; Humans; Male; Methionine; Middle Aged; Movement Disorders; Pharmacogenetics; Plant Extracts; Polymorphism, Genetic; Predictive Value of Tests; Regression Analysis; Schizophrenia; Severity of Illness Index; Treatment Outcome; Valine | 2012 |
Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prodrugs; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Valacyclovir; Valine | 2003 |
Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Catechol O-Methyltransferase; Dopamine; Female; Genotype; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory Disorders; Methionine; Neuropsychological Tests; Olanzapine; Polymorphism, Genetic; Prefrontal Cortex; Prospective Studies; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Valine | 2004 |
Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Case-Control Studies; Catechol O-Methyltransferase; Double-Blind Method; Female; Genotype; Humans; Male; Memory, Short-Term; Mental Status Schedule; Methionine; Neuropsychological Tests; Polymorphism, Genetic; Retrospective Studies; Schizophrenia; Valine | 2004 |
BDNF gene is a risk factor for schizophrenia in a Scottish population.
Topics: Adult; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Gene Frequency; Genetic Predisposition to Disease; Genetics, Population; Haplotypes; Humans; Linkage Disequilibrium; Methionine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Reference Values; Risk Factors; Schizophrenia; Scotland; Valine; White People | 2005 |
A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype.
Topics: Amino Acid Substitution; Bipolar Disorder; Catechol O-Methyltransferase; Gene Expression; Gene Expression Regulation, Enzymologic; Genetic Predisposition to Disease; Humans; Methionine; Polymorphism, Genetic; Prefrontal Cortex; Protein Isoforms; Schizophrenia; Valine | 2006 |
Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
Topics: Adolescent; Adult; Catechol O-Methyltransferase; Electroencephalography; Event-Related Potentials, P300; Female; Genotype; Humans; Male; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Single Nucleotide; Prefrontal Cortex; Psychometrics; Schizophrenia; Schizotypal Personality Disorder; Valine | 2007 |
BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
Topics: Analysis of Variance; Antipsychotic Agents; Body Mass Index; Brain-Derived Neurotrophic Factor; Chronic Disease; Female; Genotype; Humans; Inpatients; Male; Methionine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Schizophrenia; Sex Factors; Valine; Weight Gain | 2008 |
Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
Topics: Adult; Antipsychotic Agents; Catechol O-Methyltransferase; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Genetic Predisposition to Disease; Genotype; Humans; Longitudinal Studies; Male; Methionine; Neuropsychological Tests; Phenotype; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Valine | 2008 |
114 other study(ies) available for valine and Schizophrenia
Article | Year |
---|---|
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia.
Topics: Antipsychotic Agents; Diagnosis, Differential; Drug Monitoring; Early Diagnosis; Humans; Membrane Transport Modulators; Mood Disorders; Patient Care; Patient Education as Topic; Psychology; Risk Assessment; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine | 2020 |
Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Diagnosis, Differential; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2020 |
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders.
Topics: Adult; Catechol O-Methyltransferase; Cognition; Comorbidity; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Executive Function; Female; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Random Allocation; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Valine | 2017 |
Early trauma and clinical features of schizophrenia cases influenced by the BDNF Val66Met allele.
Topics: Adolescent; Adult; Brain-Derived Neurotrophic Factor; Child Abuse; DNA Mutational Analysis; Female; Genetic Association Studies; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology; Valine; Young Adult | 2018 |
Association between function and structure of the triple network and catechol-O-methyltransferase val
Topics: Adult; Catechol O-Methyltransferase; Cerebral Cortex; Female; Humans; Magnetic Resonance Imaging; Male; Methionine; Nerve Net; Polymorphism, Single Nucleotide; Principal Component Analysis; Schizophrenia; Valine; Young Adult | 2018 |
BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
Topics: Adult; Anxiety; Brain-Derived Neurotrophic Factor; Case-Control Studies; China; Depression; Ethnicity; Female; Humans; Linear Models; Male; Methionine; Polymorphism, Genetic; Schizophrenia; Valine | 2013 |
Hippocampal dysfunction in schizophrenia: association with brain-derived neurotrophic factor genotype.
Topics: Brain-Derived Neurotrophic Factor; Cohort Studies; Female; Genetic Association Studies; Genotype; Hippocampus; Humans; Male; Memory, Short-Term; Methionine; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Psychotic Disorders; Schizophrenia; Valine | 2013 |
Effect of COMT Val(158)Met genotype on nicotine withdrawal-related cognitive dysfunction in smokers with and without schizophrenia.
Topics: Analysis of Variance; Catechol O-Methyltransferase; Female; Genotype; Humans; Male; Methionine; Schizophrenia; Schizophrenic Psychology; Smoking; Tobacco Use Disorder; Valine | 2013 |
The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
Topics: Adult; Analysis of Variance; Asian People; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Valine; Young Adult | 2014 |
Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Child Abuse; Female; Gene-Environment Interaction; Genotype; Hippocampus; Humans; Male; Methionine; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; RNA, Messenger; Schizophrenia; Surveys and Questionnaires; Valine; Young Adult | 2014 |
The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Female; Genotype; Humans; Interleukin-1beta; Interleukin-2; Interleukin-6; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Valine; Weight Gain | 2015 |
Lack of meta-analytic evidence for an impact of COMT Val158Met genotype on brain activation during working memory tasks.
Topics: Brain; Catechol O-Methyltransferase; Female; Genotype; Humans; Male; Memory, Short-Term; Meta-Analysis as Topic; Methionine; Neuropsychological Tests; Schizophrenia; Valine | 2015 |
Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Actins; Action Potentials; Animals; Dendrites; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; GABAergic Neurons; Glutamate Decarboxylase; Hippocampus; Male; Maze Learning; Mice; Mice, Transgenic; Parvalbumins; Phenotype; Reflex, Startle; Schizophrenia; Somatostatin; Valine | 2015 |
[No effect of the BDNF Val66Met polymorphism on cognitive deficit in patients with schizophrenia and on the risk of the disease in their relatives].
Topics: Adult; Brain-Derived Neurotrophic Factor; Cognition Disorders; Female; Genetic Predisposition to Disease; Humans; Male; Methionine; Pedigree; Polymorphism, Genetic; Schizophrenia; Valine; Young Adult | 2015 |
BDNF rs6265 methylation and genotype interact on risk for schizophrenia.
Topics: Alleles; Animals; Basic Helix-Loop-Helix Transcription Factors; Brain-Derived Neurotrophic Factor; DNA Methylation; Epigenesis, Genetic; Female; Gene-Environment Interaction; Genotype; Homeodomain Proteins; Humans; Hypoxia; Memory, Short-Term; Methionine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Protein Binding; Risk Factors; Schizophrenia; Valine | 2016 |
COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
Topics: Adult; Aged; Catechol O-Methyltransferase; Cohort Studies; Diagnosis; Female; Gene Expression Regulation; Genotype; Glutamate Decarboxylase; Humans; Male; Memory Disorders; Memory, Short-Term; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Prefrontal Cortex; Receptors, AMPA; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Valine | 2016 |
BDNF Val66Met Genotype Interacts With a History of Simulated Stress Exposure to Regulate Sensorimotor Gating and Startle Reactivity.
Topics: Animals; Brain-Derived Neurotrophic Factor; Corticosterone; Disease Models, Animal; Female; Male; Methionine; Mice, Inbred C57BL; Prepulse Inhibition; Psychotic Disorders; Reflex, Startle; Schizophrenia; Sensory Gating; Steroids; Stress, Psychological; Valine | 2017 |
The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives.
Topics: Adult; Aged; Analysis of Variance; Catechol O-Methyltransferase; Cues; Family; Female; Genotype; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Photic Stimulation; Polymorphism, Single Nucleotide; Prefrontal Cortex; Reaction Time; Schizophrenia; Serial Learning; Valine; Young Adult | 2016 |
Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Brain-Derived Neurotrophic Factor; Chronic Disease; Female; Genetic Association Studies; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Valine; Weight Gain; Young Adult | 2016 |
Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
Topics: Adolescent; Adult; Alleles; Amino Acid Substitution; Catechol O-Methyltransferase; Dopamine; Female; Frontal Lobe; Gene Dosage; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Isoenzymes; Male; Methionine; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Reference Values; Saccades; Schizophrenia; Valine; Young Adult | 2010 |
Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.
Topics: Adult; Alleles; Amino Acid Substitution; Bipolar Disorder; Catechol O-Methyltransferase; Female; Genotype; Homozygote; Humans; Male; Methionine; Middle Aged; Multivariate Analysis; Phenotype; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Valine | 2008 |
Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.
Topics: Adult; Alanine; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Korea; Logistic Models; Male; Middle Aged; Movement Disorders; Polymorphism, Genetic; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Superoxide Dismutase; Valine | 2008 |
[ACTINg out].
Topics: Actins; Animals; Biopolymers; Brain-Derived Neurotrophic Factor; Depressive Disorder; Dopamine; Humans; Learning; Methionine; Polymorphism, Genetic; Protein-Tyrosine Kinases; Schizophrenia; Serotonin; Valine | 2008 |
Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia.
Topics: Adult; Affective Symptoms; Aged; Alleles; Bipolar Disorder; Catechol O-Methyltransferase; Female; Genotype; Homozygote; Humans; Male; Methionine; Middle Aged; Phenotype; Polymorphism, Genetic; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Schizotypal Personality Disorder; Valine | 2008 |
Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes.
Topics: Adult; Alleles; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Genetic Markers; Genotype; Haplotypes; Humans; Male; Mood Disorders; Polymorphism, Genetic; Schizophrenia; Valine | 2009 |
Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients.
Topics: Base Sequence; Catechol O-Methyltransferase; DNA Primers; Female; Genetic Predisposition to Disease; Humans; Male; Methionine; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Schizophrenia; Sex Factors; Spain; Valine | 2010 |
Association between catechol-O-methyltrasferase Val108/158Met genotype and prefrontal hemodynamic response in schizophrenia.
Topics: Adult; Amino Acid Substitution; Case-Control Studies; Catechol O-Methyltransferase; Female; Genetic Predisposition to Disease; Hemodynamics; Humans; Male; Methionine; Oxyhemoglobins; Polymorphism, Single Nucleotide; Prefrontal Cortex; Schizophrenia; Valine | 2009 |
Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
Topics: Adult; Alleles; Antipsychotic Agents; Asian People; Brain-Derived Neurotrophic Factor; Dyskinesia, Drug-Induced; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genotype; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Korea; Male; Methionine; Polymerase Chain Reaction; Polymorphism, Genetic; Schizophrenia; Valine | 2009 |
Tyrosine hydroxylase Val81Met polymorphism: lack of association with schizophrenia.
Topics: Amino Acid Substitution; Gene Frequency; Genetic Predisposition to Disease; Humans; Methionine; Polymorphism, Single Nucleotide; Schizophrenia; Tyrosine 3-Monooxygenase; Valine | 2009 |
Development of a new genotyping assay for detection of the BDNF Val66Met polymorphism using melting-curve analysis.
Topics: Alleles; Benzothiazoles; Brain-Derived Neurotrophic Factor; Diamines; DNA; Fluorescent Dyes; Genotype; Heterozygote; Homozygote; Hot Temperature; Humans; Methionine; Organic Chemicals; Polymerase Chain Reaction; Polymorphism, Genetic; Quinolines; Schizophrenia; Time Factors; Valine; White People | 2009 |
COMT val(158)met genotype and smooth pursuit eye movements in schizophrenia.
Topics: Adult; Analysis of Variance; Catechol O-Methyltransferase; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Neuropsychological Tests; Ocular Motility Disorders; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Pursuit, Smooth; Reaction Time; Schizophrenia; Valine | 2009 |
Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia.
Topics: 3' Untranslated Regions; Brain Mapping; Case-Control Studies; Catechol O-Methyltransferase; Cerebral Cortex; Dopamine Plasma Membrane Transport Proteins; Epistasis, Genetic; Genotype; Health; Humans; Methionine; Minisatellite Repeats; Polymorphism, Single Nucleotide; Schizophrenia; Valine | 2009 |
Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Atrophy; Brain-Derived Neurotrophic Factor; Female; Genetic Predisposition to Disease; Hippocampus; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Schizophrenia; Valine; Young Adult | 2010 |
Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.
Topics: Adolescent; Age Factors; Analysis of Variance; Brain Mapping; Case-Control Studies; Catechol O-Methyltransferase; Cerebral Cortex; Child; Cross-Sectional Studies; DiGeorge Syndrome; Female; Humans; Image Processing, Computer-Assisted; Intelligence; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methionine; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Valine; Young Adult | 2009 |
Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia.
Topics: Adolescent; Adult; Brain Mapping; Catechol O-Methyltransferase; Cerebrovascular Circulation; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prefrontal Cortex; Rest; Schizophrenia; Statistics as Topic; Valine; Young Adult | 2010 |
Interaction of catechol-O-methyltransferase (COMT) Val108/158 Met genotype and risperidone treatment in Chinese Han patients with schizophrenia.
Topics: Antipsychotic Agents; Asian People; Catechol O-Methyltransferase; Follow-Up Studies; Humans; Methionine; Pharmacogenetics; Risperidone; Schizophrenia; Valine | 2010 |
The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population.
Topics: Adult; Akathisia, Drug-Induced; Asian People; Brain-Derived Neurotrophic Factor; Chi-Square Distribution; Female; Gene Frequency; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Schizophrenia; Valine | 2010 |
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia.
Topics: Adult; Aggression; Brain-Derived Neurotrophic Factor; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology; Valine | 2010 |
Association study of catechol-O-methyltransferase (COMT) gene Val158Met polymorphism with auditory P300 in Chinese Han patients with schizophrenia.
Topics: Acoustic Stimulation; Adult; Analysis of Variance; Asian People; Catechol O-Methyltransferase; Chi-Square Distribution; Electroencephalography; Event-Related Potentials, P300; Female; Gene Frequency; Genome-Wide Association Study; Genotype; Humans; Male; Methionine; Polymorphism, Single Nucleotide; Reaction Time; Schizophrenia; Valine; Young Adult | 2010 |
Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis.
Topics: Catechol O-Methyltransferase; Confidence Intervals; Europe; Female; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Heterozygote; Humans; Male; Meta-Analysis as Topic; Methionine; Polymorphism, Single Nucleotide; Schizophrenia; Valine | 2011 |
COMT Val 158 Met polymorphism is related with interpersonal problem solving in schizophrenia.
Topics: Adolescent; Adult; Alleles; Attention; Catechol O-Methyltransferase; Cognition; Female; Genetic Predisposition to Disease; Humans; Interpersonal Relations; Male; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Single Nucleotide; Problem Solving; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Valine; Young Adult | 2010 |
Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls.
Topics: Adult; Analysis of Variance; Bipolar Disorder; Catechol O-Methyltransferase; Cognition Disorders; Female; Gene Frequency; Genotype; Humans; Male; Methionine; Neuropsychological Tests; Norway; Polymorphism, Single Nucleotide; Schizophrenia; Valine | 2010 |
Functional magnetic resonance imaging of BDNF val66met polymorphism in unmedicated subjects at high genetic risk of schizophrenia performing a verbal memory task.
Topics: Brain Mapping; Brain-Derived Neurotrophic Factor; Carbamide Peroxide; Cerebral Cortex; Genotype; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Memory Disorders; Methionine; Peroxides; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Urea; Valine; Verbal Learning | 2010 |
Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour.
Topics: Adult; Alleles; Amino Acid Substitution; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Male; Methionine; Middle Aged; Parents; Polymorphism, Single Nucleotide; RNA, Messenger; Schizophrenia; Suicide; Suicide, Attempted; Valine | 2011 |
Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine.
Topics: Angiotensin II Type 1 Receptor Blockers; Antipsychotic Agents; Benzimidazoles; Benzoates; Benzodiazepines; Female; Humans; Hyperinsulinism; Insulin Resistance; Male; Middle Aged; Olanzapine; Receptor, Angiotensin, Type 1; Schizophrenia; Telmisartan; Tetrazoles; Valine; Valsartan | 2011 |
Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
Topics: Adolescent; Age of Onset; Catechol O-Methyltransferase; Genetic Predisposition to Disease; Humans; Male; Marijuana Abuse; Marijuana Smoking; Methionine; Polymorphism, Genetic; Psychotic Disorders; Schizophrenia; Valine | 2011 |
Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain.
Topics: Catechol O-Methyltransferase; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Marijuana Smoking; Polymorphism, Single Nucleotide; Schizophrenia; Spain; Valine | 2011 |
Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.
Topics: Adult; Aspartic Acid; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Creatine; Female; Genetic Association Studies; Genotype; Glutamic Acid; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Memory; Methionine; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Protons; Schizophrenia; Valine; Verbal Learning | 2012 |
Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Topics: Adult; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Egypt; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia; Statistics, Nonparametric; Valine; Young Adult | 2012 |
Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia.
Topics: Adult; Brain-Derived Neurotrophic Factor; Decision Support Techniques; Deuterium Oxide; Female; Genotype; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Methionine; Neuropsychological Tests; Oxygen; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Rest; Schizophrenia; Valine; Young Adult | 2013 |
A mutation in NPAS3 segregates with mental illness in a small family.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Cells, Cultured; DNA Mutational Analysis; Family Health; Female; Green Fluorescent Proteins; Humans; Isoleucine; Male; Mice; Mutation; Nerve Tissue Proteins; Neurons; Schizophrenia; Transcription Factors; Transfection; Valine | 2014 |
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
Topics: Adult; Amino Acid Substitution; Attention; Catechol O-Methyltransferase; Chronic Disease; Cognition; Dopamine; Female; Genotype; Humans; Male; Methionine; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Valine | 2002 |
[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Topics: Aged; Alleles; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Gene Frequency; Genetic Variation; Genotype; Glycine; Haplotypes; Humans; Male; Middle Aged; Mutation; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Schizophrenia; Superoxide Dismutase; Valine | 2003 |
Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia.
Topics: Adult; Amino Acid Substitution; Catechol O-Methyltransferase; Codon; Gene Frequency; Genetic Variation; Humans; Male; Methionine; Middle Aged; Mutation, Missense; Polymorphism, Genetic; Schizophrenia; Valine | 2003 |
Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing.
Topics: Acoustic Stimulation; Adult; Alleles; Brain; Case-Control Studies; Catechol O-Methyltransferase; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Prefrontal Cortex; Schizophrenia; Valine | 2003 |
An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Brain; Brain-Derived Neurotrophic Factor; Clozapine; Drug Resistance; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Mutation; Polymorphism, Genetic; Schizophrenia; Valine | 2003 |
Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
Topics: Adult; Alanine; Analysis of Variance; Bipolar Disorder; Blotting, Southern; Case-Control Studies; Catechol O-Methyltransferase; Chromosomes, Human, Pair 22; Cyclophilins; Depressive Disorder, Major; Female; Genotype; Glycine; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Prefrontal Cortex; Proline Oxidase; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Valine | 2004 |
COMT158 polymorphism and hostility.
Topics: Antipsychotic Agents; Benzodiazepines; Catechol O-Methyltransferase; Clozapine; Genotype; Haloperidol; Hostility; Humans; Methionine; Olanzapine; Polymorphism, Genetic; Risperidone; Schizophrenia; Schizophrenic Psychology; Valine | 2004 |
Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
Topics: Adolescent; Adult; Age of Onset; Aged; Catechol O-Methyltransferase; Chronic Disease; Cognition Disorders; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Psychiatric Status Rating Scales; Regression Analysis; Schizophrenia; Severity of Illness Index; Valine | 2004 |
Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
Topics: Adult; Amino Acid Substitution; Catechol O-Methyltransferase; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Methionine; Middle Aged; Mutation; Polymorphism, Genetic; Risk Factors; Schizophrenia; Sex Factors; Turkey; Valine | 2004 |
Catechol O-methyltransferase polymorphism and eye tracking in schizophrenia: a preliminary report.
Topics: Adult; Catechol O-Methyltransferase; Dopamine; Genotype; Humans; Methionine; Ocular Motility Disorders; Polymorphism, Genetic; Prefrontal Cortex; Pursuit, Smooth; Schizophrenia; Valine | 2004 |
Negative association between catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia.
Topics: Adult; Amino Acid Substitution; Antipsychotic Agents; Brain Chemistry; Catechol O-Methyltransferase; Cohort Studies; Disease Progression; DNA Mutational Analysis; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Schizophrenia; Valine | 2005 |
COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
Topics: Acoustic Stimulation; Adolescent; Adult; Catechol O-Methyltransferase; Child; Chromosomes, Human, Pair 22; Cognition Disorders; Electroencephalography; Evoked Potentials, Auditory; Female; Frontal Lobe; Gene Deletion; Genetic Predisposition to Disease; Humans; Male; Methionine; Neuropsychological Tests; Phenotype; Risk Factors; Schizophrenia; Temporal Lobe; Valine | 2005 |
Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects.
Topics: Adult; Calcium; Drinking Behavior; Extracellular Space; Female; Gene Frequency; Genetic Variation; Genotype; Humans; Hyponatremia; Male; Middle Aged; Models, Molecular; Orexin Receptors; Peptidyl-Dipeptidase A; Polymorphism, Single Nucleotide; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Valine | 2005 |
Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.
Topics: Adolescent; Adult; Analysis of Variance; Case-Control Studies; Catechol O-Methyltransferase; Chi-Square Distribution; Cognition Disorders; Confidence Intervals; DNA Mutational Analysis; Female; Genotype; Humans; Male; Methionine; Middle Aged; Motor Skills Disorders; Neuropsychological Tests; Odds Ratio; Polymorphism, Genetic; Psychiatric Status Rating Scales; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Schizophrenic Psychology; Valine | 2005 |
COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study.
Topics: Case-Control Studies; Catechol O-Methyltransferase; Female; Humans; Male; Methionine; Mutation, Missense; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide; Reference Values; Schizophrenia; Valine | 2005 |
Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants.
Topics: Adult; Age of Onset; Brain-Derived Neurotrophic Factor; Chi-Square Distribution; Female; Genetic Variation; Glycine; Humans; Male; Methionine; Polymorphism, Genetic; Receptors, Dopamine D2; Receptors, Dopamine D3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Serine; Valine | 2005 |
No association between schizophrenia and polymorphisms in COMT in two large samples.
Topics: Case-Control Studies; Catechol O-Methyltransferase; Female; Genetic Markers; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Ireland; Jews; Linkage Disequilibrium; Male; Methionine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Schizophrenia; Valine; White People | 2005 |
Association of DRD2 gene variant with schizophrenia.
Topics: Adolescent; Adult; Age of Onset; Case-Control Studies; Chi-Square Distribution; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Histidine; Humans; Male; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Valine | 2006 |
Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients.
Topics: Adult; Aggression; Catechol O-Methyltransferase; Cognition; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Valine | 2006 |
Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Catechol O-Methyltransferase; Cognition Disorders; Female; Genotype; Humans; Male; Middle Aged; Neuropsychological Tests; Phenotype; Polymorphism, Genetic; Prefrontal Cortex; Schizophrenia; Schizophrenic Psychology; Statistics as Topic; Valine; Wechsler Scales | 2006 |
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Topics: Adult; Age of Onset; Aged; Amino Acid Substitution; Antipsychotic Agents; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Drug Resistance; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Schizophrenia; Valine | 2006 |
Comments on "Association between Ala-9Val polymorphism of MnSOD gene and schizophrenia" by O. Akyol et al. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 2005, 123-131.
Topics: Alanine; Humans; Polymorphism, Genetic; Schizophrenia; Superoxide Dismutase; Valine | 2006 |
Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
Topics: Adult; Amino Acid Substitution; Catechol O-Methyltransferase; Female; Genetic Variation; Genotype; Humans; Male; Methionine; Middle Aged; Personality Disorders; Polymorphism, Single Nucleotide; Prefrontal Cortex; Psychological Tests; Reference Values; Schizophrenia; Schizotypal Personality Disorder; Valine | 2006 |
Prefrontal electrophysiologic "noise" and catechol-O-methyltransferase genotype in schizophrenia.
Topics: Acoustic Stimulation; Adolescent; Adult; Analysis of Variance; Catechol O-Methyltransferase; Confidence Intervals; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Noise; Odds Ratio; Polymorphism, Single Nucleotide; Prefrontal Cortex; Retrospective Studies; Schizophrenia; Sex Factors; Valine | 2006 |
A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia.
Topics: Animals; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Leucine; Male; Mutation, Missense; Neuregulin-1; Pedigree; Protein Structure, Tertiary; Schizophrenia; Sequence Homology; Valine | 2006 |
Associations between COMTVal158Met polymorphism and cognition: direct or indirect effects?
Topics: Adult; Alleles; Attention; Catechol O-Methyltransferase; Cognition Disorders; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Reaction Time; Risk; Schizophrenia; Schizotypal Personality Disorder; Valine | 2006 |
Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Topics: Adult; Brain; Brain Mapping; Brain-Derived Neurotrophic Factor; Cognition Disorders; Female; Genetic Variation; Genotype; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Neuropsychological Tests; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology; Temporal Lobe; Valine | 2006 |
COMT Association Data in Schizophrenia: New Caveats.
Topics: Asia; Catechol O-Methyltransferase; Community Health Planning; Europe; Genetic Predisposition to Disease; Humans; Meta-Analysis as Topic; Methionine; Odds Ratio; Schizophrenia; Valine | 2006 |
M129V variation in the prion protein gene and psychotic disorders: relationship to neuropsychological and psychopathological measures.
Topics: Adult; Aged; Alleles; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Homozygote; Humans; Male; Methionine; Middle Aged; Neuropsychological Tests; Phenotype; Polymorphism, Genetic; Prion Proteins; Prions; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Valine; Wechsler Scales | 2007 |
Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis.
Topics: Adolescent; Adult; Alleles; Amino Acid Substitution; Brain; Catechol O-Methyltransferase; Cohort Studies; Dominance, Cerebral; Dopamine; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Methionine; Neuropsychological Tests; Polymorphism, Single Nucleotide; Prefrontal Cortex; Risk Factors; Schizophrenia; Schizophrenic Language; Schizophrenic Psychology; Scotland; Valine | 2007 |
No association between Ala9Val functional polymorphism of MnSOD gene and schizophrenia in a representative Italian sample.
Topics: Adult; Alanine; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Italy; Male; Middle Aged; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Superoxide Dismutase; Valine | 2006 |
DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability.
Topics: Adolescent; Adult; Alleles; Catechol O-Methyltransferase; Female; Genotype; Humans; Male; Memory, Short-Term; Methionine; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Dopamine D2; Reference Values; Risk Factors; Schizophrenia; Serial Learning; Synaptic Transmission; Valine; Verbal Learning | 2007 |
COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
Topics: Adult; Antipsychotic Agents; Catechol O-Methyltransferase; Clozapine; Cognition Disorders; Cohort Studies; Female; Follow-Up Studies; Genotype; Heterozygote; Homozygote; Humans; Male; Memory, Short-Term; Methionine; Neuropsychological Tests; Polymorphism, Single Nucleotide; Problem Solving; Prospective Studies; Schizophrenia; Treatment Outcome; Valine | 2007 |
Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children.
Topics: Adolescent; Adult; Brain; Catechol O-Methyltransferase; Child; Child Development; Cognition; England; Female; Frontal Lobe; Genetic Predisposition to Disease; Genetic Testing; Humans; Intelligence; Longitudinal Studies; Male; Methionine; Neuropsychological Tests; Polymorphism, Genetic; Prefrontal Cortex; Puberty; Schizophrenia; Sex Factors; Valine | 2007 |
Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome.
Topics: Adult; Alleles; Amino Acid Substitution; Arousal; Chromosome Deletion; Chromosomes, Human, Pair 22; Female; Frontal Lobe; Gene Expression; Genetic Carrier Screening; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia; Syndrome; Valine | 2007 |
No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.
Topics: Adult; Asian People; Brain-Derived Neurotrophic Factor; Case-Control Studies; DNA Mutational Analysis; Female; Humans; Male; Meta-Analysis as Topic; Methionine; Middle Aged; Polymorphism, Genetic; Schizophrenia; Valine | 2007 |
Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
Topics: Adult; Africa, Southern; Alanine; Chi-Square Distribution; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Movement Disorders; Polymorphism, Genetic; Schizophrenia; Superoxide Dismutase; Valine | 2007 |
Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
Topics: Amino Acid Substitution; Brain; Brain Chemistry; Catechol O-Methyltransferase; Cognition Disorders; Cognitive Behavioral Therapy; DNA Mutational Analysis; Female; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Methionine; Neuropsychological Tests; Polymorphism, Genetic; Quality of Life; Recovery of Function; Schizophrenia; Treatment Outcome; Valine | 2007 |
Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome.
Topics: Adolescent; Adult; Brain Mapping; Case-Control Studies; Catechol O-Methyltransferase; Cerebral Cortex; Chromosome Deletion; Chromosomes, Human, Pair 22; Developmental Disabilities; Female; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methionine; Neuropsychological Tests; Oxygen; Schizophrenia; Valine | 2007 |
The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Asparagine; Chi-Square Distribution; Discoidin Domain Receptor 1; DNA Mutational Analysis; Exons; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Receptor Protein-Tyrosine Kinases; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Schizophrenia; Serine; Valine | 2007 |
Effect of catechol O-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia.
Topics: Adult; Amino Acid Substitution; Antipsychotic Agents; Catechol O-Methyltransferase; Evoked Potentials, Auditory; Female; Humans; Male; Methionine; Middle Aged; Phenotype; Polymorphism, Genetic; Regression Analysis; Schizophrenia; Smoking; Valine | 2007 |
COMT val158Met and executive control: a test of the benefit of specific deficits to translational research.
Topics: Adult; Alleles; Catechol O-Methyltransferase; Chromosome Mapping; Chromosomes, Human, Pair 22; Female; Genetic Markers; Genotype; Humans; Male; Methionine; Middle Aged; Neuropsychological Tests; Phenotype; Polymorphism, Single Nucleotide; Protein Biosynthesis; Risk Factors; Schizophrenia; Schizophrenic Psychology; Valine | 2007 |
Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
Topics: Adult; Alanine; Alleles; Antipsychotic Agents; Chromosomes, Human, Pair 6; Dyskinesia, Drug-Induced; Female; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Reference Values; Schizophrenia; Superoxide Dismutase; Valine | 2007 |
The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Antipsychotic Agents; Catechol O-Methyltransferase; Cognition; Humans; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Valine | 2007 |
COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Catechol O-Methyltransferase; Genotype; Humans; Methionine; Olanzapine; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Valine | 2007 |
Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls.
Topics: Adult; Case-Control Studies; Catechol O-Methyltransferase; Family Health; Female; Genotype; Humans; Male; Memory, Short-Term; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Schizophrenia; Valine | 2008 |
Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.
Topics: Adult; Alleles; Catechol O-Methyltransferase; Cognition; DNA Mutational Analysis; Family; Female; Gene Frequency; Humans; Male; Memory, Short-Term; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Problem Solving; Receptors, Dopamine D4; Schizophrenia; Valine; Verbal Behavior | 2007 |
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide.
Topics: Adult; Bipolar Disorder; Female; Gene Expression; Humans; Male; Middle Aged; Models, Molecular; Prefrontal Cortex; Receptor, Serotonin, 5-HT2C; Risk Factors; RNA Editing; RNA, Messenger; Schizophrenia; Schizophrenic Psychology; Serine; Suicide; Valine | 2008 |
Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia.
Topics: Adult; Alleles; Asian People; Brain-Derived Neurotrophic Factor; Chromosomes, Human, Pair 11; Chronic Disease; Comorbidity; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; RNA, Messenger; Schizophrenia; Smoking; Tobacco Use Disorder; Valine | 2007 |
The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia.
Topics: Adult; Age of Onset; Aged; Amino Acid Substitution; Female; Genetic Predisposition to Disease; Genotype; Humans; Hyponatremia; Isoleucine; Male; Middle Aged; Orexin Receptors; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Schizophrenia; Thirst; Valine | 2007 |
Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia.
Topics: Adult; Antipsychotic Agents; Atrophy; Brain; Brain-Derived Neurotrophic Factor; Cognition Disorders; Female; Frontal Lobe; Genetic Variation; Genotype; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methionine; Neuronal Plasticity; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Valine | 2007 |
Catechol-O-methyltransferase Val158Met polymorphism and clinical characteristics in first episode non-affective psychosis.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age of Onset; Amino Acid Substitution; Catechol O-Methyltransferase; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Psychotic Disorders; Schizophrenia; Valine | 2008 |
Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia.
Topics: Adult; Amino Acid Substitution; Catechol O-Methyltransferase; Cognition; DNA Methylation; Dopamine; Epigenesis, Genetic; Female; Genotype; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Models, Biological; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission; Valine | 2008 |
Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.
Topics: Adult; Bipolar Disorder; Catechol O-Methyltransferase; Depressive Disorder, Major; Family; Female; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Male; Methionine; Middle Aged; Pedigree; Personality; Personality Assessment; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology; Schizotypal Personality Disorder; Self Concept; Surveys and Questionnaires; Valine | 2008 |
Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.
Topics: Adult; Amino Acid Substitution; Atrophy; Brain; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Female; Functional Laterality; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Japan; Magnetic Resonance Imaging; Male; Methionine; Parahippocampal Gyrus; Polymorphism, Genetic; Schizophrenia; Valine | 2008 |
Evidence that the COMTVal158Met polymorphism moderates subclinical psychotic and affective symptoms in unaffected first-degree relatives of patients with schizophrenia.
Topics: Adult; Brief Psychiatric Rating Scale; Catechol O-Methyltransferase; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Psychotic Disorders; Risk Factors; Schizophrenia; Valine | 2008 |
The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.
Topics: Adolescent; Adult; Brain-Derived Neurotrophic Factor; Dominance, Cerebral; Female; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Magnetic Resonance Imaging; Male; Methionine; Polymorphism, Genetic; Receptors, Dopamine D3; Schizophrenia; Serine; Temporal Lobe; Thalamus; Valine | 2008 |
Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia.
Topics: Brain-Derived Neurotrophic Factor; Case-Control Studies; Cohort Studies; Female; Fetal Hypoxia; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Risk Factors; Schizophrenia; Valine | 2008 |
Preferential transmission of the high activity allele of COMT in schizophrenia.
Topics: Adolescent; Adult; Alleles; Catechol O-Methyltransferase; China; Chromosome Mapping; Chromosomes, Human, Pair 22; Disease Susceptibility; Female; Humans; Male; Methionine; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Schizophrenia; Valine | 1996 |
Allelic association of the MTHFR gene with schizophrenia.
Topics: Alanine; Alleles; Amino Acid Substitution; Female; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Nuclear Family; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Schizophrenia; Valine | 1999 |
Split verdict on schizophrenia.
Topics: Alanine; Alzheimer Disease; Amyloid beta-Protein Precursor; Chromosomes, Human, Pair 11; Codon; DNA; Humans; Mutation; Schizophrenia; Valine | 1992 |
Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Glutamates; Glutamic Acid; Humans; Male; Phencyclidine; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma; Schizophrenia; Valine | 1987 |
Plasma-aminoacid levels in Huntington's chorea.
Topics: Adult; Alanine; Amino Acids; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine; Valine | 1969 |